Understand the source comparison
Best Peptides for Immune System: Mechanism Comparison
The table below compares immune-modulating peptides by pathway, target tissue, and documented research outcomes. Thymalin Upregulates thymulin production in thymic epithelial cells Thymus gland, T-cell maturation Restored CD4/CD8 ratios in aging adults by 37%
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The table below compares immune-modulating peptides by pathway, target tissue, and documented research outcomes.
- Thymalin
- Upregulates thymulin production in thymic epithelial cells
- Thymus gland, T-cell maturation
- Restored CD4/CD8 ratios in aging adults by 37% (2021 study)
- 10–20 mg IM every 48 hours for 10 days
- Best choice for age-related T-cell decline. Targets the root cause (thymic involution) rather than downstream symptoms.
- KPV
- Inhibits NF-κB nuclear translocation
- Intracellular, cytokine gene transcription
- Reduced IBD inflammation markers by 62% without systemic immunosuppression
- 500 mcg–2 mg SC 3–5×/week
- Most selective anti-inflammatory peptide. Preserves pathogen defense while blocking cytokine cascade at the gene level.
- TB-500
- Sequesters G-actin, modulates macrophage polarization
- Tissue microenvironment, regulatory T-cells
- Increased Treg populations by 43% in inflammation models
- 2–5 mg SC twice weekly
- Unique immune angle. Doesn't stimulate or suppress, but shifts the resolution phase to prevent chronic inflammation.
- LL-37
- Antimicrobial peptide, modulates TLR signaling
- Epithelial barriers, innate immunity
- Enhanced pathogen clearance in sepsis models; reduced bacterial load by 58%
- 1–3 mg SC daily
- Direct antimicrobial action plus immune signaling. Valuable in infection-prone contexts, less relevant for autoimmune or chronic inflammation.